Why Is Moderna (MRNA) Stock Down 5.35% Today, Sep 30? Citi Sell Downgrade and Patent Lawsuit Weigh on MRNA
Moderna (MRNA) stock fell 5.35% to $192.57 on September 30, 2026, as Citi cut the stock to Sell on valuation concerns after the oncology rally, while a recent patent ruling added legal-risk context. This report reviews the daily setup, the immediate risks and the technical levels traders are watching.